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SUMMARY. In order to develop an approach to evaluate the preabsorptive behavior of supramolecular
aggregate carriers, three commercial oral formulations of a mixture of lipophilic and hydrophilic vitamins
dispersed in water-glycerin-polysorbate-80 (PS-80) vehicle were subjected to dynamic light scattering and
electrokinetic determinations. They exhibited diffusion coefficients ranging from 4.46 .10–9 to 3.22 .10–8
cm2/s. To mimic in vivo environment the formulations were progressively diluted with water and simulat-
ed gastric and intestinal fluids until a ratio 1:10. Hydrodynamic diameters (dH) at 37 °C and electrokinetic
potentials of each formulation remained almost unchanged in the three assayed conditions. However, the
average dH were 1.00, 1.36 and 1.63 times higher than a reference dispersion of PS-80 revealing significant
differences among formulations. Concentration of PS-80 in diluted samples is about 103 times above its
critical micellar concentration. Therefore, loaded core/shell micelles appears to be robust drug carriers
that will interact with the gastrointestinal membranes upon administration. The observed differences in
size and/or shape would be related to the biopharmaceutical performance of multisource products. Be-
sides, the developed approach could be used in developing and control stages of such pharmaceutical sys-
tems. 
